{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:46:47Z","timestamp":1794358007854,"version":"4.9.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022822","name":"MSD Animal Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.03.032","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T05:15:25Z","timestamp":1711170925000},"page":"2895-2908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens"],"prefix":"10.1016","volume":"42","author":[{"given":"Jerome D.G.","family":"Comes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4121-0972","authenticated-orcid":false,"given":"Kristel","family":"Doets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijmen","family":"Zegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Slits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noortje M.P.","family":"van de Weem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M.","family":"van Oers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle C.W.","family":"van Hulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Langereis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-0408","authenticated-orcid":false,"given":"Gorben P.","family":"Pijlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.05.006","article-title":"H5N1 vaccines in humans","volume":"178","author":"Baz","year":"2013","journal-title":"Virus Res"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2024.03.032_b0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2024.03.032_b0015","first-page":"153","article-title":"Development and application of avian influenza vaccines in China","volume":"Vol. 333","author":"Chen","year":"2009"},{"issue":"5","key":"10.1016\/j.vaccine.2024.03.032_b0020","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1128\/jvi.76.5.2384-2392.2002","article-title":"The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids","volume":"76","author":"Chevalier","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.03.032_b0025","article-title":"Infectious clone of a contemporary Tembusu virus and replicons expressing reporter genes or heterologous antigens from poultry viruses","volume":"e2300254","author":"Comes","year":"2023","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2024.03.032_b0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virusres.2016.08.005","article-title":"Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada","volume":"226","author":"Crawford","year":"2016","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.032_b0035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/21645515.2017.1377871","article-title":"Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry","volume":"14","author":"Cruz","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"15","key":"10.1016\/j.vaccine.2024.03.032_b0040","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/bioinformatics\/btp250","article-title":"VARNA: Interactive drawing and editing of the RNA secondary structure","volume":"25","author":"Darty","year":"2009","journal-title":"Bioinformatics"},{"issue":"555","key":"10.1016\/j.vaccine.2024.03.032_b0045","doi-asserted-by":"crossref","first-page":"eabc9396","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.032_b0050","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.vaccine.2009.10.015","article-title":"Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: Proof of concept","volume":"28","author":"Erdman","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2024.03.032_b0055","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.gt.3301469","article-title":"Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons","volume":"8","author":"Furler","year":"2001","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2024.03.032_b0060","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/JVI.02073-06","article-title":"The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff","volume":"81","author":"Garmashova","year":"2007","journal-title":"J Virol"},{"issue":"36","key":"10.1016\/j.vaccine.2024.03.032_b0065","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.032_b0070","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1099\/vir.0.80677-0","article-title":"Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon","volume":"86","author":"Gehrke","year":"2005","journal-title":"J Gen Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2024.03.032_b0075","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/pathogens10081010","article-title":"New insights into the biology of the emerging Tembusu virus","volume":"10","author":"Hamel","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2024.03.032_b0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.vaccine.2024.03.032_b0085","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/eji.202149785","article-title":"Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects","volume":"52","author":"Haveri","year":"2022","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2024.03.032_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.694959","article-title":"Replication\/assembly defective avian flavivirus with internal deletions in the capsid can be used as an approach for living attenuated vaccine","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2024.03.032_b0095","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/JVI.03361-12","article-title":"Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus","volume":"87","author":"Herbert","year":"2013","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.03.032_b0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/03079457.2014.973832","article-title":"Tembusu-like flavivirus (Perak virus) as the cause of neurological disease outbreaks in young Pekin ducks","volume":"43","author":"Homonnay","year":"2014","journal-title":"Avian Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.032_b0105","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.vaccine.2009.09.133","article-title":"Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates","volume":"28","author":"Hooper","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.032_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/srep35537","article-title":"Viral fusion efficacy of specific H3N2 influenza virus reassortant combinations at single-particle level","volume":"6","author":"Hsu","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.032_b0115","first-page":"289","article-title":"Characterization of two recombinant HVT-IBD vaccines by VP2 insert detection and cell-mediated immunity after vaccination of specific pathogen-free chickens","volume":"46","author":"Ingrao","year":"2017","journal-title":"Avian Pathol J World Vet Poultry Assoc"},{"issue":"29","key":"10.1016\/j.vaccine.2024.03.032_b0120","doi-asserted-by":"crossref","first-page":"24473","DOI":"10.1074\/jbc.M112.356113","article-title":"Host proteolytic activity Is necessary for infectious bursal disease virus capsid protein assembly","volume":"287","author":"Irigoyen","year":"2012","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.vaccine.2024.03.032_b0125","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1021\/acs.langmuir.2c02657","article-title":"Lipid nanoparticle and liposome reference materials: Assessment of size homogeneity and long-term -70 \u00b0C and 4 \u00b0C storage stability","volume":"39","author":"Jakubek","year":"2023","journal-title":"Langmuir: ACS J Surf Colloids"},{"issue":"14","key":"10.1016\/j.vaccine.2024.03.032_b0130","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/JVI.75.14.6719-6728.2001","article-title":"Essential role of cyclization sequences in flavivirus RNA replication","volume":"75","author":"Khromykh","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-019-0153-1","article-title":"Heterologous viral protein interactions within licensed seasonal influenza virus vaccines","volume":"5","author":"Koroleva","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2024.03.032_b0140","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol Biol Evol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41541-021-00390-9","article-title":"An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats","volume":"6","author":"Langereis","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.032_b0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biologicals.2009.12.004","article-title":"Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China","volume":"38","author":"Li","year":"2010","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.032_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0018197","article-title":"Identification of a cryptic prokaryotic promoter within the cDNA encoding the 5\u2032 end of dengue virus RNA genome","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.03.032_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virol.2019.01.004","article-title":"Recombinant turkey herpesvirus expressing H9 hemagglutinin providing protection against H9N2 avian influenza","volume":"529","author":"Liu","year":"2019","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2024.03.032_b0165","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1128\/JVI.00243-13","article-title":"Novel cis-acting element within the capsid-coding region enhances flavivirus viral-RNA replication by regulating genome cyclization","volume":"87","author":"Liu","year":"2013","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.20506\/rst.26.1.1742","article-title":"The use of vaccination in poultry production","volume":"26","author":"Marangon","year":"2006","journal-title":"Rev Sci Tech Off Int Epiz"},{"issue":"11","key":"10.1016\/j.vaccine.2024.03.032_b0175","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1128\/JVI.77.11.6438-6449.2003","article-title":"The oligomerization domain of VP3, the scaffolding protein of infectious bursal disease virus, plays a critical role in capsid assembly","volume":"77","author":"Maraver","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0180","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.vaccine.2024.03.032_b0185","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ymthe.2019.08.007","article-title":"Immunogenicity of RNA replicons encoding HIV Env immunogens designed for self-assembly into nanoparticles","volume":"27","author":"Melo","year":"2019","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170080","article-title":"Non-lytic egression of infectious bursal disease virus (IBDV) particles from infected cells","volume":"12","author":"M\u00e9ndez","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1472-6750-13-67","article-title":"Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applications","volume":"13","author":"Minskaia","year":"2013","journal-title":"BMC Biotech"},{"issue":"19","key":"10.1016\/j.vaccine.2024.03.032_b0200","doi-asserted-by":"crossref","first-page":"12416","DOI":"10.1128\/JVI.79.19.12416-12424.2005","article-title":"Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors","volume":"79","author":"Mishin","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.032_b0205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vacune.2023.03.001","article-title":"Vaccination against COVID-19 from 6 months of age on. Completing the circle of prevention in paediatrics","volume":"24","author":"Moraga-Llop","year":"2023","journal-title":"Vacunas (English Edition)"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2024.03.032_b0210","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/S0264-410X(00)00428-X","article-title":"Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems","volume":"19","author":"Morris-Downes","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.032_b0215","series-title":"Molecular Evolution and Phylogenetics","author":"Nei","year":"2000"},{"issue":"12","key":"10.1016\/j.vaccine.2024.03.032_b0220","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1128\/JVI.79.12.7597-7608.2005","article-title":"Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells","volume":"79","author":"Petrakova","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.032_b0225","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/JVI.75.3.1252-1264.2001","article-title":"Characterization of cell lines carrying self-replicating hepatitis C virus RNAs","volume":"75","author":"Pietschmann","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.032_b0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1517\/14712598.6.2.135","article-title":"Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications","volume":"6","author":"Pijlman","year":"2006","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.032_b0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00071669608417862","article-title":"Plasma viscosity values and the relationship with age and sex in normal commercial broiler and layer strains of chickens","volume":"37","author":"Robertson","year":"1996","journal-title":"Br Poult Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2024.03.032_b0240","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0958-1669(99)00006-3","article-title":"Alphavirus vectors for gene expression and vaccines","volume":"10","author":"Schlesinger","year":"1999","journal-title":"Curr Opin Biotechnol"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2024.03.032_b0245","first-page":"533","article-title":"Chimeras in noncoding regions between serotypes I and II of segment A of infectious bursal disease virus are viable and show pathogenic phenotype in chickens","volume":"81","author":"Schr\u00f6der","year":"2000","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/viro.2000.0635","article-title":"Influenza virus (A\/HK\/156\/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses","volume":"278","author":"Schultz-Cherry","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.03.032_b0255","first-page":"9","article-title":"Avian influenza viruses in Hong Kong: zoonotic considerations","volume":"Vol. 1","author":"Shortridge","year":"2005"},{"issue":"9","key":"10.1016\/j.vaccine.2024.03.032_b0260","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/v11090784","article-title":"A recombinant turkey herpesvirus expressing F and HN genes of avian avulavirus-1 (AAvV-1) genotype VI confers cross-protection against challenge with virulent AAvV-1 genotypes IV and VII in chickens","volume":"11","author":"\u015amietanka","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.032_b0265","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2307\/1590923","article-title":"Group and strain-specific neutralization sites of infectious bursal disease virus defined with monoclonal antibodies","volume":"32","author":"Snyder","year":"1988","journal-title":"Avian Dis"},{"issue":"4 SUPPL.1","key":"10.1016\/j.vaccine.2024.03.032_b0270","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1637\/10183-041012-Review.1","article-title":"Impact of vaccines and vaccination on global control of avian influenza","volume":"56","author":"Swayne","year":"2012","journal-title":"Avian Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2024.03.032_b0275","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1016\/j.vaccine.2007.02.011","article-title":"Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection","volume":"25","author":"Sylte","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2024.03.032_b0280","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.vaccine.2017.12.025","article-title":"A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR\/Cas9 system","volume":"36","author":"Tang","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2024.03.032_b0285","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/CVI.00065-14","article-title":"Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients","volume":"21","author":"van der Velden","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.032_b0290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/03079457.2020.1828567","article-title":"Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek\u2019s disease viruses","volume":"50","author":"van Hulten","year":"2021","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2024.03.032_b0295","doi-asserted-by":"crossref","first-page":"RRN1123","DOI":"10.1371\/currents.RRN1123","article-title":"Rapid development of an efficacious swine vaccine for novel H1N1","volume":"1","author":"Vander Veen","year":"2009","journal-title":"PLoS Curr"},{"issue":"11","key":"10.1016\/j.vaccine.2024.03.032_b0300","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.vaccine.2012.01.030","article-title":"Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine","volume":"30","author":"Vander Veen","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2024.03.032_b0305","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/viro.1998.9564","article-title":"Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes","volume":"255","author":"Varnavski","year":"1999","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2024.03.032_b0310","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/JVI.74.9.4394-4403.2000","article-title":"Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors","volume":"74","author":"Varnavski","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.03.032_b0320","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1038\/srep07630","article-title":"Poultry farms as a source of avian influenza A (H7N9) virus reassortment and human infection","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.032_b0325","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cimid.2008.01.005","article-title":"Epidemiology of H5N1 avian influenza","volume":"32","author":"Yee","year":"2009","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2024.03.032_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.886873","article-title":"Identification of a novel insertion site HVT-005\/006 for the generation of recombinant turkey herpesvirus vector","volume":"13","author":"Zai","year":"2022","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.03.032_b0335","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s11427-018-9420-1","article-title":"Vaccination of poultry successfully eliminated human infection with H7N9 virus in China","volume":"61","author":"Zeng","year":"2018","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.vaccine.2024.03.032_b0340","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"2","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:16:18Z","timestamp":1712967378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24003190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24003190"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}